Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.

Veloso TR, Mancini S, Giddey M, Vouillamoz J, Que YA, Moreillon P, Entenza JM.

Vaccine. 2015 Jul 9;33(30):3512-7. doi: 10.1016/j.vaccine.2015.05.060. Epub 2015 Jun 3.

PMID:
26048778
2.

In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.

Mancini S, Laurent F, Veloso TR, Giddey M, Vouillamoz J, Vandenesch F, Moreillon P, Entenza JM.

Antimicrob Agents Chemother. 2015 Apr;59(4):2435-8. doi: 10.1128/AAC.04733-14. Epub 2015 Jan 20.

3.

Assessment of the in vitro synergy of daptomycin plus linezolid against multidrug-resistant enterococci.

Entenza JM, Giddey M, Vouillamoz J, Moreillon P, Mancini S.

J Glob Antimicrob Resist. 2014 Dec;2(4):306-308. doi: 10.1016/j.jgar.2014.09.004. Epub 2014 Oct 2.

PMID:
27873692
4.

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Veloso TR, Que YA, Chaouch A, Giddey M, Vouillamoz J, Rousson V, Moreillon P, Entenza JM.

J Infect Dis. 2015 Jan 1;211(1):72-9. doi: 10.1093/infdis/jiu426. Epub 2014 Aug 1.

PMID:
25086177
5.

A quorum sensing small volatile molecule promotes antibiotic tolerance in bacteria.

Que YA, Hazan R, Strobel B, Maura D, He J, Kesarwani M, Panopoulos P, Tsurumi A, Giddey M, Wilhelmy J, Mindrinos MN, Rahme LG.

PLoS One. 2013 Dec 19;8(12):e80140. doi: 10.1371/journal.pone.0080140. eCollection 2013.

6.

Rapid detection of Staphylococcus aureus strains with reduced susceptibility to vancomycin by isothermal microcalorimetry.

Entenza JM, Bétrisey B, Manuel O, Giddey M, Sakwinska O, Laurent F, Bizzini A.

J Clin Microbiol. 2014 Jan;52(1):180-6. doi: 10.1128/JCM.01820-13. Epub 2013 Nov 6.

7.

In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia.

Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G.

Antimicrob Agents Chemother. 2013 Dec;57(12):6276-83. doi: 10.1128/AAC.01701-13. Epub 2013 Oct 7.

8.

Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.

Vouillamoz J, Entenza JM, Giddey M, Fischetti VA, Moreillon P, Resch G.

Int J Antimicrob Agents. 2013 Nov;42(5):416-21. doi: 10.1016/j.ijantimicag.2013.06.020. Epub 2013 Aug 9.

PMID:
23992647
9.

Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis.

Veloso TR, Zbinden A, Andreoni F, Giddey M, Vouillamoz J, Moreillon P, Zinkernagel AS, Entenza JM.

Int J Med Microbiol. 2013 Dec;303(8):498-504. doi: 10.1016/j.ijmm.2013.06.006. Epub 2013 Jun 20.

PMID:
23856340
10.

A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus.

Guignard B, Vouillamoz J, Giddey M, Moreillon P.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):899-907. doi: 10.1007/s10096-013-1824-x. Epub 2013 Jan 31.

PMID:
23370969
11.

Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P, Que YA, Rousson V, Moreillon P, Entenza JM.

Infect Immun. 2013 Mar;81(3):697-703. doi: 10.1128/IAI.01030-12. Epub 2012 Dec 17.

12.

Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis.

Roger T, Delaloye J, Chanson AL, Giddey M, Le Roy D, Calandra T.

J Infect Dis. 2013 Jan 15;207(2):331-9. doi: 10.1093/infdis/jis673. Epub 2012 Nov 2.

PMID:
23125447
13.

Antimicrobial resistance of Staphylococcus aureus strains acquired by pig farmers from pigs.

Oppliger A, Moreillon P, Charrière N, Giddey M, Morisset D, Sakwinska O.

Appl Environ Microbiol. 2012 Nov;78(22):8010-4. doi: 10.1128/AEM.01902-12. Epub 2012 Sep 7.

14.

High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.

Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2012 Aug;56(8):4511-5. Epub 2012 May 29.

15.

Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.

Moreillon P, Bizzini A, Giddey M, Vouillamoz J, Entenza JM.

J Antimicrob Chemother. 2012 Mar;67(3):652-60. doi: 10.1093/jac/dkr521. Epub 2011 Dec 13.

PMID:
22167243
16.

Histone deacetylase inhibitors impair antibacterial defenses of macrophages.

Mombelli M, Lugrin J, Rubino I, Chanson AL, Giddey M, Calandra T, Roger T.

J Infect Dis. 2011 Nov;204(9):1367-74. doi: 10.1093/infdis/jir553. Epub 2011 Sep 15.

PMID:
21921209
17.

Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Pea F, Cojutti P, Petrosillo N, Furlanut M, Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):4496; author reply 4496-7. doi: 10.1128/AAC.00603-11. No abstract available.

18.

Staphylococcus aureus host range and human-bovine host shift.

Sakwinska O, Giddey M, Moreillon M, Morisset D, Waldvogel A, Moreillon P.

Appl Environ Microbiol. 2011 Sep;77(17):5908-15. doi: 10.1128/AEM.00238-11. Epub 2011 Jul 8.

19.

In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Majcherczyk P, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):3977-84. doi: 10.1128/AAC.00402-11. Epub 2011 Jul 5.

20.

Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.

Veloso TR, Amiguet M, Rousson V, Giddey M, Vouillamoz J, Moreillon P, Entenza JM.

Infect Immun. 2011 May;79(5):2006-11. doi: 10.1128/IAI.01208-10. Epub 2011 Feb 14.

21.

Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Jan;55(1):385-7. doi: 10.1128/AAC.00811-10. Epub 2010 Oct 18.

22.

Ecological temporal stability of Staphylococcus aureus nasal carriage.

Sakwinska O, Blanc DS, Lazor-Blanchet C, Moreillon M, Giddey M, Moreillon P.

J Clin Microbiol. 2010 Aug;48(8):2724-8. doi: 10.1128/JCM.02091-09. Epub 2010 Jun 2.

23.

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.

Entenza JM, Giddey M, Vouillamoz J, Moreillon P.

Int J Antimicrob Agents. 2010 May;35(5):451-6. doi: 10.1016/j.ijantimicag.2009.12.022. Epub 2010 Feb 24.

PMID:
20185277
24.

Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.

Haenni M, Galofaro L, Ythier M, Giddey M, Majcherczyk P, Moreillon P, Madec JY.

Antimicrob Agents Chemother. 2010 Mar;54(3):1140-5. doi: 10.1128/AAC.00915-09. Epub 2010 Jan 11.

25.

Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.

Entenza JM, Haldimann A, Giddey M, Lociuro S, Hawser S, Moreillon P.

Antimicrob Agents Chemother. 2009 Sep;53(9):3635-41. doi: 10.1128/AAC.00325-09. Epub 2009 Jun 29.

26.

Genetic diversity and ecological success of Staphylococcus aureus strains colonizing humans.

Sakwinska O, Kuhn G, Balmelli C, Francioli P, Giddey M, Perreten V, Riesen A, Zysset F, Blanc DS, Moreillon P.

Appl Environ Microbiol. 2009 Jan;75(1):175-83. doi: 10.1128/AEM.01860-08. Epub 2008 Oct 31.

27.

In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.

Vouillamoz J, Moreillon P, Giddey M, Entenza JM.

J Antimicrob Chemother. 2008 Feb;61(2):371-4. Epub 2007 Nov 22.

PMID:
18033780
28.

Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis.

Vankerckhoven V, Moreillon P, Piu S, Giddey M, Huys G, Vancanneyt M, Goossens H, Entenza JM.

J Med Microbiol. 2007 Aug;56(Pt 8):1017-24.

PMID:
17644707
29.

Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.

Vouillamoz J, Moreillon P, Giddey M, Entenza JM.

J Antimicrob Chemother. 2006 Dec;58(6):1208-14. Epub 2006 Oct 9.

PMID:
17030515
30.

Getting a fair hearing: a small step towards client empowerment.

Giddey M.

J Psychiatr Ment Health Nurs. 1994;1(3):187. No abstract available.

PMID:
15835322
31.

Mental health forum. 1. Home is where the heart is.

Giddey M.

Nurs Mirror. 1983 Jan 5;156(1):36-8. No abstract available.

PMID:
6549854
32.

Careers - child/adolescent psychiatry: a family affair.

Giddey M.

Nurs Mirror. 1982 Mar 10;154(10):50. No abstract available.

PMID:
6917261

Supplemental Content

Loading ...
Support Center